04/16/2024
6:34 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2024
3:32 PM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024
4:27 PM | Virax Biolabs Group (Filer)
| Form 424B5 | |
01/22/2024
4:28 PM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/12/2024
6:43 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/21/2023
6:34 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
3:12 PM | Virax Biolabs Group (Filer)
| Form 424B3 | |
12/18/2023
6:37 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2023
11:15 PM | Virax Biolabs Group (Filer)
| Form EFFECT | |
12/14/2023
6:43 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
5:03 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023
3:38 PM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023
3:05 PM | Virax Biolabs Group (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/12/2023
7:00 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
6:24 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
6:49 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/01/2023
6:37 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/03/2023
7:39 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2023
6:58 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
3:31 PM | Virax Biolabs Group (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
06/14/2023
7:00 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/04/2023
6:56 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
